Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc.（CERE）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CERE · 截至 2026年6月9日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
27
近12个月
买卖比
0.15
Buy/Sell (by trades)
整体情绪
Cerevel Therapeutics Holdings, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CERE 季度内部人买卖趋势
CERE 内幕交易卖出 · CERE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
CERE 高管卖出股份 · CERE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 1, 2024 | PFIZER INC 10% Owner | Other | 27,349,211 | $1.23B⚡ | Form 4 |
| Aug 1, 2024 | BAIN CAPITAL INVESTORS LLC Director | Other | 65,679,781 | $2.96B⚡ | Form 4 |
| Aug 1, 2024 | Gordon Christopher R Director | Other | 3,282 | $148K | Form 4 |
| Aug 1, 2024 | Gordon Christopher R Director | Other | 65,679,781 | $2.96B⚡ | Form 4 |
| Aug 1, 2024 | Gordon Christopher R Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | Koppel Adam Director | Other | 3,282 | $148K | Form 4 |
| Aug 1, 2024 | Koppel Adam Director | Other | 65,679,781 | $2.96B⚡ | Form 4 |
| Aug 1, 2024 | Koppel Adam Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | Sanchez Ramiro Chief Medical Officer | Other | 14,673 | $660K | Form 4 |
| Aug 1, 2024 | Giordano Douglas E. Director | Other | 3,282 | $148K | Form 4 |
| Aug 1, 2024 | Giordano Douglas E. Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | Renaud Ronald C JR President & CEO · Director | Other | 83,857 | $3.77M⚡ | Form 4 |
| Aug 1, 2024 | Mckernan Ruth Director | Other | 3,282 | $148K | Form 4 |
| Aug 1, 2024 | Mckernan Ruth Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | Akamine Scott Chief Legal Officer | Other | 7,527 | $339K | Form 4 |
| Aug 1, 2024 | Sulzberger Gabrielle Director | Other | 48,415 | $2.18M⚡ | Form 4 |
| Aug 1, 2024 | Sulzberger Gabrielle Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | Renger John Chief Scientific Officer | Other | 6,370 | $287K | Form 4 |
| Aug 1, 2024 | DiPietro Kenneth Chief Human Resources Officer | Other | 25,042 | $1.13M⚡ | Form 4 |
| Aug 1, 2024 | Tregoning Kathleen See Remarks | Other | 10,666 | $480K | Form 4 |
| Aug 1, 2024 | DEKKERS MARIJN E Director | Other | 31,822 | $1.43M⚡ | Form 4 |
| Aug 1, 2024 | DEKKERS MARIJN E Director | Other | 402,326 | $18.10M⚡ | Form 4 |
| Aug 1, 2024 | DEKKERS MARIJN E Director | Other | 10,461 | — | Form 4 |
| Aug 1, 2024 | ALTSCHULLER Susan CFO | Other | 16,913 | $761K | Form 4 |
| Aug 1, 2024 | RIEDEL NORBERT G Director | Other | 46,092 | $2.07M⚡ | Form 4 |
Renaud Ronald C JR
President & CEO · Director
日期
Aug 1
股数
83,857
均价
$45.00
总金额
$3.77M ⚡
DiPietro Kenneth
Chief Human Resources Officer
日期
Aug 1
股数
25,042
均价
$45.00
总金额
$1.13M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CERE 内幕交易
CERE 内幕交易
Cerevel Therapeutics Holdings, Inc.（CERE）内幕交易数据来源于公司内部人（包括CERE）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CERE内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cerevel Therapeutics Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CERE 内幕交易 · 5个问题Cerevel Therapeutics Holdings, Inc.（CERE）的内部人包括高管和董事，如CERE等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026